Citadel Advisors
LICN icon

Citadel Advisors’s Lichen China LICN Stock Holding History

Citadel Advisors’s Portfolio LICN Stock Details LICN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-242
Closed -$87.4K – 15006
2024
Q3 		$87.4K Sell
242
-64
-21% -$24.6K ﹤0.01% 11298
2024
Q2 		$88.7K Buy
+306
New +$78.5K ﹤0.01% 11085

Other funds holding LICN

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return

Citadel Advisors's LICN Position: Q4 2024 in Review

Citadel Advisors sold out of Lichen China (LICN) in Q4 2024, closing a stake of 242 shares — an estimated $87.4K sold.

Citadel Advisors first reported a position in LICN in Q2 2024 and held it in 2 quarters. The position peaked at $88.7K in Q2 2024. 7 funds tracked by Wall St. Rank hold LICN as of Q4 2024.

  • Citadel Advisors reported no remaining Lichen China position as of Q4 2024 after selling out during the quarter.
  • Citadel Advisors sold 242 Lichen China shares in Q4 2024, an estimated $87.4K.
  • Citadel Advisors first reported a position in Lichen China in Q2 2024 and held it in 2 quarters.
  • Citadel Advisors's Lichen China position peaked at $88.7K in Q2 2024.
  • 7 funds tracked by Wall St. Rank held Lichen China as of Q4 2024.

Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.